FOXM1 and breast cancer: Although the mechanism of FoxM1 and OGlcNAcylation is poorly characterized, sentinel studies suggest that hyper O-GlcNAcylation of FoxM1 mediators in breast cancer prevent the degradation of FoxM1, to promote transformation of cells in breast cancer (Caldwell et al., 2010).